2. UROART Symposium
Datum
12.01.2024Veranstaltungsort
Universitätsspital Basel4031 Basel
Organisator
UROART BaselAnmeldeschluss
11.01.2024Online-Anmeldung
Dear Ladies and Gentlemen,
We would like to invite you to our 2nd UROART Symposium on 12th January 2024 in Basel at the Universitätsspital
In December 2022, the council of the European Union announced the intention to consider extending targeted cancer screening beyond breast, colorectal and cervical cancer to include prostate cancer. The recommendation encourages countries to evaluate the feasibility and effectiveness of the implementation of organized screening programs for prostate cancer to reduce the burden of the disease and its mortality through early detection, based on the latest available scientific developments and evidence. However, the case is not so clear with conclusive evidence still out there; while data from the Unites States reveal an upsurge in advanced and metastatic prostate cancer cases after the USPSTF recommendation against PSA screening, recent results of the PROTECT trial question the survival benefit of whole gland treatment in localized prostate cancer. Therefore, we are more than delighted to welcome some the most renewed experts for early detection of prostate cancer at the second UROART event in Basel for scientific exchange and debate on this emerging topic. To screen or not to screen will be the question during our morning session.
In the second half of the day, we will focus on the optimal management of men with very high-risk or locally advanced prostate cancer whose disease were most likely not detected early. The aim in these men is avoiding metastatic disease while preserving quality of life. An excellent panel of interdisciplinary speakers will give state of the art lectures on diagnostic pathways and treatment options in this population. We are very much looking forward to welcoming you at our second UROART event in Basel.
Prof. Helge Seifert PD Dr. Ashkan Mortezavi Thomas J. Lautenschlager
Head of Urology Scientific Program Director Senior Healthcare Expart
Programm Freitag, 12. Januar 2024
| Zeit | Thema | Moderation/Speaker |
|---|---|---|
| 08:45 - 08:55 |
Welcome speech |
Prof. Helge Seifert |
| 08:55 - 09:00 |
Prostate Cancer in Switzerland |
PD Dr. Ashkan Mortezavi On behalf of the Swiss Prostate Cancer Screening Working Group |
|
Session 1 – Early detection |
Chairs: Prof. Per Anders Abrahamsson (Lund University) and Prof. Cyrill Rentsch (Universitätsspital Basel) |
|
| 09:00 - 09:30 |
Prime time for organised, risk-adapted prostate cancer screening - Impact of the EU recommendations
 |
Prof. Hein Van Poppel, Chair of the EAU Policy Office |
| 09:30 - 10:00 |
Prostate cancer screening, the current status in Europe: first results from the PRAISE-U project
|
Prof. Monique Roobol, Erasmus Medical Centre Rotterdam |
| 10:00 - 10:30 |
Early detection in the context of ProtecT: more harm than good?
|
Prof. Freddie Hamdy, Nuffield Department of Surgical Sciences, University of Oxford |
| 10:30 - 11:00 |
Coffee break |
|
| 11:00 - 11:30 |
Novel strategies for prostate cancer screening – the Stockholm trials
|
Ass. Prof. Tobias Nordström, PhD, Danderyd Sjukhus / Karolinska Institutet Stockholm |
| 11:30 - 12:00 |
Risk adapted PSA screening - first results from the PROBASE trial
|
Prof. Peter Albers, Heinrich-Heine-University Düsseldorf |
| 12:00 - 12:15 |
Discussion |
|
| 12:15 - 13:15 |
Lunch |
|
|
Session 2 – Treating high risk non-metastatic prostate cancer
|
Chairs: Prof. Derya Tilki (Martini Klinik Hamburg) and Prof. Frank Stenner (Universitätsspital Basel) |
|
| 13:15 - 13:45 |
Role of PSMA PET CT for local staging of prostate cancer
|
Prof. Irene Burger, Kantonsspital Baden |
| 13:45 - 14:15 |
Identifying the optimal candidates for pelvic lymph node dissection during prostatectomy
|
Prof. Alberto Briganti, Università Vita-Salute San Raffaele, Milan |
| 14:15 - 14:45 |
Robotic prostatectomy for high risk locally-advanced prostate cancer: techniques and outcomes from the highest volume UK centre
|
Prof. Prabhakar Rajan, University College London Hospitals |
| 14:45 - 15:15 |
Coffee break |
|
| 15:15 - 15:45 |
Surgery or radiotherapy for locally advanced prostate cancer
|
Prof. Piet Ost, Ghent University |
| 15:45 - 16:15 |
Treatment intensification for high-risk, locally advanced and N+ prostate cancer
|
Prof. Silke Gillessen, Oncology Institute of Southern Switzerland, EOC, Bellinzona |
| 16:15 - 16:30 |
Discussion |
Preise in CHF
| Was | Plätze | Bezeichnung | Preis |
|---|---|---|---|
| Participation fee | 150 |
Normal price
135.00
resident/researcher
85.00
|
|
Annullationsbedingungen
Wir danken Ihnen für Ihre verbindliche Anmeldung und weisen Sie im folgenden Abschnitt auf unsere Annullationsbedingungen hin.Bei einer Annullation bis/ ab
- 30 - 15 Tage vor der Veranstaltung verrechnen wir 50%
- 14 Tage vor der Veranstaltung oder bei Nichterscheinen verrechnen wir 100%
Tritt der/die Teilnehmer/in vor den oben genannten Fristen zurück, behalten wir uns vor, eine Annullationsgebühr von CHF 30.- für administrative Aufwände zu berechnen. Sie haben jedoch immer die Möglichkeit, eine Ersatzperson zu schicken.
Mit Ihrer Anmeldung bestätigen Sie, diese Bedingungen akzeptiert und gelesen zu haben.
Anmeldeschluss
11.01.2024Online-Anmeldung
Hauptsponsor
Sponsoren
